1 Market Overview of Thrombolytic Therapy 1.1 Thrombolytic Therapy Market Overview 1.1.1 Thrombolytic Therapy Product Scope 1.1.2 Thrombolytic Therapy Market Status and Outlook 1.2 Global Thrombolytic Therapy Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Thrombolytic Therapy Market Size by Region (2016-2027) 1.4 Global Thrombolytic Therapy Historic Market Size by Region (2016-2021) 1.5 Global Thrombolytic Therapy Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Thrombolytic Therapy Market Size (2016-2027) 1.6.1 North America Thrombolytic Therapy Market Size (2016-2027) 1.6.2 Europe Thrombolytic Therapy Market Size (2016-2027) 1.6.3 Asia-Pacific Thrombolytic Therapy Market Size (2016-2027) 1.6.4 Latin America Thrombolytic Therapy Market Size (2016-2027) 1.6.5 Middle East & Africa Thrombolytic Therapy Market Size (2016-2027) 2 Thrombolytic Therapy Market Overview by Type 2.1 Global Thrombolytic Therapy Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Thrombolytic Therapy Historic Market Size by Type (2016-2021) 2.3 Global Thrombolytic Therapy Forecasted Market Size by Type (2022-2027) 2.4 Drug Treatment 2.5 Surgical Treatment 2.6 Other Treatment 3 Thrombolytic Therapy Market Overview by Application 3.1 Global Thrombolytic Therapy Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Thrombolytic Therapy Historic Market Size by Application (2016-2021) 3.3 Global Thrombolytic Therapy Forecasted Market Size by Application (2022-2027) 3.4 Acute Myocardial Infarction 3.5 Pulmonary Embolism 3.6 Deep Vein Thrombosis 3.7 Blocking the Catheter 3.8 Acute Ischemic Stroke 4 Thrombolytic Therapy Competition Analysis by Players 4.1 Global Thrombolytic Therapy Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thrombolytic Therapy as of 2020) 4.3 Date of Key Players Enter into Thrombolytic Therapy Market 4.4 Global Top Players Thrombolytic Therapy Headquarters and Area Served 4.5 Key Players Thrombolytic Therapy Product Solution and Service 4.6 Competitive Status 4.6.1 Thrombolytic Therapy Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Roche 5.1.1 Roche Profile 5.1.2 Roche Main Business 5.1.3 Roche Thrombolytic Therapy Products, Services and Solutions 5.1.4 Roche Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.1.5 Roche Recent Developments 5.2 Boehringer Ingelheim 5.2.1 Boehringer Ingelheim Profile 5.2.2 Boehringer Ingelheim Main Business 5.2.3 Boehringer Ingelheim Thrombolytic Therapy Products, Services and Solutions 5.2.4 Boehringer Ingelheim Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.2.5 Boehringer Ingelheim Recent Developments 5.3 Mochida Pharmaceutical 5.3.1 Mochida Pharmaceutical Profile 5.3.2 Mochida Pharmaceutical Main Business 5.3.3 Mochida Pharmaceutical Thrombolytic Therapy Products, Services and Solutions 5.3.4 Mochida Pharmaceutical Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.3.5 NanJing Nanda Pharmaceutical Recent Developments 5.4 NanJing Nanda Pharmaceutical 5.4.1 NanJing Nanda Pharmaceutical Profile 5.4.2 NanJing Nanda Pharmaceutical Main Business 5.4.3 NanJing Nanda Pharmaceutical Thrombolytic Therapy Products, Services and Solutions 5.4.4 NanJing Nanda Pharmaceutical Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.4.5 NanJing Nanda Pharmaceutical Recent Developments 5.5 Wanhua Biochem 5.5.1 Wanhua Biochem Profile 5.5.2 Wanhua Biochem Main Business 5.5.3 Wanhua Biochem Thrombolytic Therapy Products, Services and Solutions 5.5.4 Wanhua Biochem Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.5.5 Wanhua Biochem Recent Developments 5.6 Tianjin Biochem Pharmaceutical 5.6.1 Tianjin Biochem Pharmaceutical Profile 5.6.2 Tianjin Biochem Pharmaceutical Main Business 5.6.3 Tianjin Biochem Pharmaceutical Thrombolytic Therapy Products, Services and Solutions 5.6.4 Tianjin Biochem Pharmaceutical Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.6.5 Tianjin Biochem Pharmaceutical Recent Developments 5.7 Livzon Pharmaceutical Group 5.7.1 Livzon Pharmaceutical Group Profile 5.7.2 Livzon Pharmaceutical Group Main Business 5.7.3 Livzon Pharmaceutical Group Thrombolytic Therapy Products, Services and Solutions 5.7.4 Livzon Pharmaceutical Group Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.7.5 Livzon Pharmaceutical Group Recent Developments 5.8 Sedico Pharmaceuticals 5.8.1 Sedico Pharmaceuticals Profile 5.8.2 Sedico Pharmaceuticals Main Business 5.8.3 Sedico Pharmaceuticals Thrombolytic Therapy Products, Services and Solutions 5.8.4 Sedico Pharmaceuticals Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.8.5 Sedico Pharmaceuticals Recent Developments 5.9 Microbix 5.9.1 Microbix Profile 5.9.2 Microbix Main Business 5.9.3 Microbix Thrombolytic Therapy Products, Services and Solutions 5.9.4 Microbix Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.9.5 Microbix Recent Developments 5.10 Syner-Med 5.10.1 Syner-Med Profile 5.10.2 Syner-Med Main Business 5.10.3 Syner-Med Thrombolytic Therapy Products, Services and Solutions 5.10.4 Syner-Med Thrombolytic Therapy Revenue (US$ Million) & (2016-2021) 5.10.5 Syner-Med Recent Developments 6 North America 6.1 North America Thrombolytic Therapy Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Thrombolytic Therapy Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Thrombolytic Therapy Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Thrombolytic Therapy Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Thrombolytic Therapy Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Thrombolytic Therapy Market Dynamics 11.1 Thrombolytic Therapy Industry Trends 11.2 Thrombolytic Therapy Market Drivers 11.3 Thrombolytic Therapy Market Challenges 11.4 Thrombolytic Therapy Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Thrombolytic Therapy Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Thrombolytic Therapy Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Thrombolytic Therapy Market Size Share by Region (2016-2021) Table 4. Global Thrombolytic Therapy Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Thrombolytic Therapy Forecasted Market Size Share by Region (2022-2027) Table 6. Global Thrombolytic Therapy Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Thrombolytic Therapy Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Thrombolytic Therapy Revenue Market Share by Type (2016-2021) Table 9. Global Thrombolytic Therapy Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Thrombolytic Therapy Revenue Market Share by Type (2022-2027) Table 11. Global Thrombolytic Therapy Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Thrombolytic Therapy Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Thrombolytic Therapy Revenue Market Share by Application (2016-2021) Table 14. Global Thrombolytic Therapy Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Thrombolytic Therapy Revenue Market Share by Application (2022-2027) Table 16. Global Thrombolytic Therapy Revenue (US$ Million) by Players (2016-2021) Table 17. Global Thrombolytic Therapy Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thrombolytic Therapy as of 2020) Table 19. Date of Key Manufacturers Enter into Thrombolytic Therapy Market Table 20. Global Thrombolytic Therapy Top Players Headquarters and Area Served Table 21. Thrombolytic Therapy Product Solution and Service Table 22. Global Thrombolytic Therapy Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Roche Basic Information List Table 25. Roche Description and Business Overview Table 26. Roche Thrombolytic Therapy Products, Services and Solutions Table 27. Revenue (US$ Million) in Thrombolytic Therapy Business of Roche (2016-2021) Table 28. Roche Recent Developments Table 29. Boehringer Ingelheim Basic Information List Table 30. Boehringer Ingelheim Description and Business Overview Table 31. Boehringer Ingelheim Thrombolytic Therapy Products, Services and Solutions Table 32. Revenue (US$ Million) in Thrombolytic Therapy Business of Boehringer Ingelheim (2016-2021) Table 33. Boehringer Ingelheim Recent Developments Table 34. Mochida Pharmaceutical Basic Information List Table 35. Mochida Pharmaceutical Description and Business Overview Table 36. Mochida Pharmaceutical Thrombolytic Therapy Products, Services and Solutions Table 37. Revenue (US$ Million) in Thrombolytic Therapy Business of Mochida Pharmaceutical (2016-2021) Table 38. Mochida Pharmaceutical Recent Developments Table 39. NanJing Nanda Pharmaceutical Basic Information List Table 40. NanJing Nanda Pharmaceutical Description and Business Overview Table 41. NanJing Nanda Pharmaceutical Thrombolytic Therapy Products, Services and Solutions Table 42. Revenue (US$ Million) in Thrombolytic Therapy Business of NanJing Nanda Pharmaceutical (2016-2021) Table 43. NanJing Nanda Pharmaceutical Recent Developments Table 44. Wanhua Biochem Basic Information List Table 45. Wanhua Biochem Description and Business Overview Table 46. Wanhua Biochem Thrombolytic Therapy Products, Services and Solutions Table 47. Revenue (US$ Million) in Thrombolytic Therapy Business of Wanhua Biochem (2016-2021) Table 48. Wanhua Biochem Recent Developments Table 49. Tianjin Biochem Pharmaceutical Basic Information List Table 50. Tianjin Biochem Pharmaceutical Description and Business Overview Table 51. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Products, Services and Solutions Table 52. Revenue (US$ Million) in Thrombolytic Therapy Business of Tianjin Biochem Pharmaceutical (2016-2021) Table 53. Tianjin Biochem Pharmaceutical Recent Developments Table 54. Livzon Pharmaceutical Group Basic Information List Table 55. Livzon Pharmaceutical Group Description and Business Overview Table 56. Livzon Pharmaceutical Group Thrombolytic Therapy Products, Services and Solutions Table 57. Revenue (US$ Million) in Thrombolytic Therapy Business of Livzon Pharmaceutical Group (2016-2021) Table 58. Livzon Pharmaceutical Group Recent Developments Table 59. Sedico Pharmaceuticals Basic Information List Table 60. Sedico Pharmaceuticals Description and Business Overview Table 61. Sedico Pharmaceuticals Thrombolytic Therapy Products, Services and Solutions Table 62. Revenue (US$ Million) in Thrombolytic Therapy Business of Sedico Pharmaceuticals (2016-2021) Table 63. Sedico Pharmaceuticals Recent Developments Table 64. Microbix Basic Information List Table 65. Microbix Description and Business Overview Table 66. Microbix Thrombolytic Therapy Products, Services and Solutions Table 67. Revenue (US$ Million) in Thrombolytic Therapy Business of Microbix (2016-2021) Table 68. Microbix Recent Developments Table 69. Syner-Med Basic Information List Table 70. Syner-Med Description and Business Overview Table 71. Syner-Med Thrombolytic Therapy Products, Services and Solutions Table 72. Revenue (US$ Million) in Thrombolytic Therapy Business of Syner-Med (2016-2021) Table 73. Syner-Med Recent Developments Table 74. North America Thrombolytic Therapy Market Size by Country (2016-2021) & (US$ Million) Table 75. North America Thrombolytic Therapy Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe Thrombolytic Therapy Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe Thrombolytic Therapy Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific Thrombolytic Therapy Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific Thrombolytic Therapy Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific Thrombolytic Therapy Market Share by Region (2016-2021) Table 81. Asia-Pacific Thrombolytic Therapy Market Share by Region (2022-2027) Table 82. Latin America Thrombolytic Therapy Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America Thrombolytic Therapy Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa Thrombolytic Therapy Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa Thrombolytic Therapy Market Size by Country (2022-2027) & (US$ Million) Table 86. Thrombolytic Therapy Market Trends Table 87. Thrombolytic Therapy Market Drivers Table 88. Thrombolytic Therapy Market Challenges Table 89. Thrombolytic Therapy Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global Thrombolytic Therapy Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Thrombolytic Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Thrombolytic Therapy Market Share by Regions: 2021 VS 2027 Figure 4. Global Thrombolytic Therapy Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Thrombolytic Therapy Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Thrombolytic Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Thrombolytic Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Thrombolytic Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Thrombolytic Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Thrombolytic Therapy Market Size Share by Type in 2021 & 2027 Figure 11. Drug Treatment Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Surgical Treatment Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Other Treatment Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global Thrombolytic Therapy Market Size Share by Application in 2021 & 2027 Figure 15. Acute Myocardial Infarction Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Pulmonary Embolism Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Deep Vein Thrombosis Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Blocking the Catheter Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Acute Ischemic Stroke Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Thrombolytic Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Top 5 and Top 10 Players Thrombolytic Therapy Market Share in 2020 Figure 22. North America Thrombolytic Therapy Market Share by Country (2016-2027) Figure 23. United States Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 24. Canada Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 25. Germany Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 26. France Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 27. U.K. Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 28. Italy Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 29. Russia Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 30. Nordic Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 31. Rest of Europe Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 32. Asia-Pacific Thrombolytic Therapy Market Share by Region (2016-2027) Figure 33. China Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 34. Japan Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 35. South Korea Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 36. Southeast Asia Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 37. India Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 38. Australia Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 39. Rest of Asia-Pacific Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 40. Latin America Thrombolytic Therapy Market Share by Country (2016-2027) Figure 41. Mexico Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 42. Brazil Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 43. Rest of Latin America Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 44. Middle East & Africa Thrombolytic Therapy Market Share by Country (2016-2027) Figure 45. Turkey Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 46. Saudi Arabia Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 47. UAE Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 48. Rest of Middle East & Africa Thrombolytic Therapy Market Size (2016-2027) & (US$ Million) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation

Roche Boehringer Ingelheim Mochida Pharmaceutical NanJing Nanda Pharmaceutical Wanhua Biochem Tianjin Biochem Pharmaceutical Livzon Pharmaceutical Group Sedico Pharmaceuticals Microbix Syner-Med